Literature DB >> 3031083

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.

F Blasi, J D Vassalli, K Danø.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3031083      PMCID： PMC2114431          DOI： 10.1083/jcb.104.4.801

Source DB:  PubMed          Journal:  J Cell Biol        ISSN： 0021-9525            Impact factor:   10.539


× No keyword cloud information.
  63 in total

1.  Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.

Authors:  P A Andreasen; L S Nielsen; P Kristensen; J Grøndahl-Hansen; L Skriver; K Danø
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

2.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

3.  Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.

Authors:  H A Chapman; Z Vavrin; J B Hibbs
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

4.  Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.

Authors:  J J Emeis; V W van Hinsbergh; J H Verheijen; G Wijngaards
Journal:  Biochem Biophys Res Commun       Date:  1983-01-27       Impact factor: 3.575

5.  A proenzyme form of human urokinase.

Authors:  T C Wun; L Ossowski; E Reich
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

6.  The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.

Authors:  W A Günzler; G J Steffens; F Otting; S M Kim; E Frankus; L Flohé
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-10

7.  Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.

Authors:  D J Crutchley; L B Conanan; J R Maynard
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

8.  Plasminogen activator and the membrane of transformed cells.

Authors:  J P Quigley; R H Goldfarb; C Scheiner; J O'Donnell-Tormey; T K Yeo
Journal:  Prog Clin Biol Res       Date:  1980

9.  Plasminogen activator released as inactive proenzyme from murine cells transformed by sarcoma virus.

Authors:  L Skriver; L S Nielsen; R Stephens; K Danø
Journal:  Eur J Biochem       Date:  1982-05-17

10.  Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

Authors:  L S Nielsen; J G Hansen; L Skriver; E L Wilson; K Kaltoft; J Zeuthen; K Danø
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162
View more
  122 in total

1.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.

Authors:  R P Czekay; T A Kuemmel; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.

Authors:  Z Y Hu; Y X Liu; K Liu; S Byrne; T Ny; Q Feng; C D Ockleford
Journal:  J Anat       Date:  1999-02       Impact factor: 2.610

Review 3.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

4.  Secretion of plasminogen activator inhibitor by normal rat pleural leukocytes in culture.

Authors:  X Y Li; G M Brown; D Lamb; K Donaldson
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Elevated urokinase-type plasminogen activator plasma levels are associated with deterioration of liver function but not with hepatocellular carcinoma.

Authors:  S Sato; T Higashi; S Ouguchi; N Hino; T Tsuji
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

6.  Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability.

Authors:  Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

7.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

8.  Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans.

Authors:  Alaka Mullick; Miria Elias; Penelope Harakidas; Anne Marcil; Malcolm Whiteway; Bing Ge; Thomas J Hudson; Antoine W Caron; Lucie Bourget; Serge Picard; Orce Jovcevski; Bernard Massie; David Y Thomas
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Testosterone upregulation of tissue type plasminogen activator expression in Sertoli cells : tPA expression in Sertoli cells.

Authors:  Jian Guo; Yu-Qiang Shi; Wei Yang; Yin-Chuan Li; Zhao-Yuan Hu; Yi-Xun Liu
Journal:  Endocrine       Date:  2007-10-09       Impact factor: 3.633

10.  Plasminogen activator inhibitor (type-1) in rat adrenal medulla.

Authors:  J Eriksen; P Kristensen; C Pyke; K Danø
Journal:  Histochemistry       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.